AI Article Synopsis
- Non-enzymatic formation of advanced glycation endproducts (AGEs) is linked to degenerative diseases by contributing to tissue aging, stiffness, and increased blood pressure.
- Binding of AGEs to the receptor RAGE causes inflammation, while its soluble form (sRAGE) can help prevent tissue injury in models of arteriosclerosis.
- AGEs can also have protective effects, such as inhibiting lung tumor growth and reducing cell damage, suggesting a complex relationship between glycation and health.
Article Abstract
Unlabelled: Non-enzymatic formation of advanced glycation endproducts (AGEs) is associated with degenerative diseases. Chronic accumulation of AGEs with age in tissues especially in the extracellular matrix is well known and at least in part responsible for e.g., collagen crosslinking, tissue stiffening and thus induction of high blood pressure or diastolic heart failure. Binding of soluble AGEs to the receptor for AGEs, RAGE, induces an inflammatory response whereas the soluble form of RAGE (sRAGE) can inhibit inflammatory tissue injury like arteriosclerosis in mouse models. However, there are a number of indications that AGEs have protective effects as well. AGEs may inhibit lung tumor growth, glyoxal induced AGE modification of human heart muscle can reduce an ischemia reperfusion injury and AGEs from nutrition can reduce ROS induced cell damage.
Conclusions: In summary, this indicates that protein glycation behaves like a double-edged sword. It induces tissue aging and degenerative diseases on the one hand, on the other hand, may also have protective effects, indicating a hormetic response.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.exger.2014.12.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!